Every result, read before it lands. Judged after.
Sign in
NIFTY 50 22,672.55 -0.45% NIFTY BANK 55,121.35 -0.01% NIFTY IT 27,965.95 -0.60% NIFTY MIDCAP 100 59,536.65 -0.38% NIFTY SMALLCAP 100 19,539.65 +0.47% NIFTY AUTO 25,154.05 -1.52% NIFTY PHARMA 26,441.55 -0.41% NIFTY FMCG 44,851.15 -0.78%
Open as of 12:13 IST · about a minute behind

All results · NIFTY PHARMA

Every judged result on record. Open a company to see its every judged result.

419results judged 25read right 28read wrong 39flat / no call 327unread
35%beat the market
-0.0%avg vs market, 10d
4.1%avg move, T+1

By company

19 companies · open one for its every result
CompanyJudgedRightWrongFlatHit rateAvg vs mkt
AJANTPHARM Ajanta Pharmaceuticals Ltd. 25 2 2 2 50% +1.0% ›
AUROPHARMA Aurobindo Pharma Ltd. 25 2 1 2 67% -1.2% ›
BIOCON Biocon Ltd. 25 1 3 1 25% +0.0% ›
GLENMARK Glenmark Pharmaceuticals Ltd. 25 0 4 2 0% +0.4% ›
IPCALAB Ipca Laboratories Ltd. 25 2 1 2 67% -0.3% ›
LAURUSLABS Laurus Labs Ltd. 25 3 2 1 60% +2.5% ›
LUPIN Lupin Ltd. 25 1 2 2 33% -2.4% ›
SUNPHARMA Sun Pharmaceutical Industries Ltd. 25 2 1 3 67% -1.5% ›
TORNTPHARM Torrent Pharmaceuticals Ltd. 25 3 0 3 100% -0.5% ›
WOCKPHARMA Wockhardt Ltd. 25 0 0 0 — +2.1% ›
DIVISLAB Divi's Laboratories Ltd. 24 2 1 3 67% -0.0% ›
DRREDDY Dr. Reddy's Laboratories Ltd. 24 2 1 2 67% -1.5% ›
CIPLA Cipla Ltd. 23 0 1 4 0% +0.7% ›
ALKEM Alkem Laboratories Ltd. 22 1 0 3 100% -1.1% ›
GLAND Gland Pharma Ltd. 22 2 3 0 40% -2.3% ›
ZYDUSLIFE Zydus Lifesciences Ltd. 17 1 1 3 50% +0.0% ›
PPLPHARMA Piramal Pharma Ltd. 16 1 2 3 33% +2.1% ›
MANKIND Mankind Pharma Ltd. 14 0 3 3 0% +0.8% ›
SAILIFE Sai Life Sciences Ltd. 7 0 0 0 — +3.9% ›

Each result

Company ResultReadOutcomeT+1T+10vs marketRun-upResultWhy
ALKEMAlkem Laboratories Ltd. 14 Aug Q1FY27 — unread +2.0% -0.7% +0.5% -3% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 4 sector peers reported the same week; the sector read may already have been set.
  • 1 more
 ›
IPCALABIpca Laboratories Ltd. 13 Aug Q1FY27 — unread +4.9% +8.6% +9.5% +4% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 4 sector peers reported the same week; the sector read may already have been set.
  • 1 more
 ›
ZYDUSLIFEZydus Lifesciences Ltd. 11 Aug Q1FY27 — unread -2.0% -3.4% -2.4% +7% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 2 more
 ›
GLANDGland Pharma Ltd. 10 Aug Q1FY27 — unread +8.4% +5.9% +6.9% +12% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 2 more
 ›
WOCKPHARMAWockhardt Ltd. 10 Aug Q1FY27 — unread -4.3% -1.6% -0.6% -1% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 4 sector peers reported the same week; the sector read may already have been set.
  • 1 more
 ›
LUPINLupin Ltd. 6 Aug Q1FY27 — unread -3.6% -7.7% -6.1% +2% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Delivery share rose 9 points in the fortnight before — someone was taking stock home.
  • 2 more
 ›
SAILIFESai Life Sciences Ltd. 6 Aug Q1FY27 — unread +0.9% +3.1% +4.7% +16% no figures
  • Ran up 16% in the 30 sessions before the result — a good number had little left to reward.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 4 more
 ›
AUROPHARMAAurobindo Pharma Ltd. 5 Aug Q1FY27 — unread +2.8% -0.3% +1.3% +5% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 2 more
 ›
BIOCONBiocon Ltd. 5 Aug Q1FY27 — unread +0.3% -3.0% -1.4% +1% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 sector peers reported the same week; the sector read may already have been set.
  • 1 more
 ›
DIVISLABDivi's Laboratories Ltd. 1 Aug Q1FY27 favourable right +4.0% +5.3% +5.7% +19% no figures
  • Ran up 19% in the 30 sessions before the result — a good number had little left to reward.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 2 more
 ›
GLENMARKGlenmark Pharmaceuticals Ltd. 31 Jul Q1FY27 unfavourable wrong -0.4% +4.3% +4.7% +1% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Delivery share rose 8 points in the fortnight before — someone was taking stock home.
  • 1 more
 ›
SUNPHARMASun Pharmaceutical Industries Ltd. 31 Jul Q1FY27 neutral neutral -1.3% -5.5% -5.1% +8% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 2 more
 ›
AJANTPHARMAjanta Pharmaceuticals Ltd. 30 Jul Q1FY27 favourable right +2.3% +6.9% +6.7% +12% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 5 sector peers reported the same week; the sector read may already have been set.
 ›
MANKINDMankind Pharma Ltd. 30 Jul Q1FY27 favourable wrong -3.6% -5.9% -6.1% +7% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Its usual continuation pattern did not hold this quarter.
  • 1 more
 ›
TORNTPHARMTorrent Pharmaceuticals Ltd. 30 Jul Q1FY27 favourable neutral +3.7% -0.8% -1.0% +10% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Its continuation habit held this quarter.
  • 1 more
 ›
PPLPHARMAPiramal Pharma Ltd. 29 Jul Q1FY27 strong right -0.0% +8.7% +8.1% +20% no figures
  • Ran up 20% in the 30 sessions before the result — a good number had little left to reward.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 2 more
 ›
LAURUSLABSLaurus Labs Ltd. 24 Jul Q1FY27 strong right +9.8% +15.8% +12.4% +15% no figures
  • The market itself moved +3.4% over the same ten sessions; the raw move is mostly tide.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 1 more
 ›
CIPLACipla Ltd. 23 Jul Q1FY27 weak wrong +1.2% +5.1% +2.1% +1% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
 ›
DRREDDYDr. Reddy's Laboratories Ltd. 22 Jul Q1FY27 weak right -2.6% -1.0% -3.7% -7% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 5% of its 52-week low.
  • 2 more
 ›
GLENMARKGlenmark Pharmaceuticals Ltd. 29 May Q4FY26 strong wrong -4.0% -5.2% -6.5% +1% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
 ›
IPCALABIpca Laboratories Ltd. 29 May Q4FY26 neutral neutral -1.1% +3.4% +2.1% +4% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Volume ran 1.6x its prior month in the fortnight before.
 ›
DIVISLABDivi's Laboratories Ltd. 23 May Q4FY26 neutral neutral -1.9% -5.3% -2.8% +17% no figures
  • Ran up 17% in the 30 sessions before the result — a good number had little left to reward.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 2 more
 ›
SUNPHARMASun Pharmaceutical Industries Ltd. 22 May Q4FY26 neutral neutral -0.2% -3.0% -0.5% +8% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 4 sector peers reported the same week; the sector read may already have been set.
 ›
TORNTPHARMTorrent Pharmaceuticals Ltd. 22 May Q4FY26 neutral neutral -0.8% -1.7% +0.8% +11% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 2 more
 ›
AUROPHARMAAurobindo Pharma Ltd. 21 May Q4FY26 strong wrong -6.0% -5.5% -4.2% +16% no figures
  • Ran up 16% in the 30 sessions before the result — a good number had little left to reward.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 more
 ›
MANKINDMankind Pharma Ltd. 19 May Q4FY26 strong wrong +0.9% -4.9% -4.0% +25% no figures
  • Ran up 25% in the 30 sessions before the result — a good number had little left to reward.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 2 more
 ›
ZYDUSLIFEZydus Lifesciences Ltd. 19 May Q4FY26 neutral neutral +1.7% +5.7% +6.6% +18% no figures
  • Ran up 18% in the 30 sessions before the result — a good number had little left to reward.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 4 more
 ›
GLANDGland Pharma Ltd. 15 May Q4FY26 strong right +20.5% +22.7% +23.8% — no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Volume ran 1.9x its prior month in the fortnight before.
  • 1 more
 ›
SAILIFESai Life Sciences Ltd. 14 May Q4FY26 — unread +0.0% +4.3% +4.9% +14% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 2 more
 ›
DRREDDYDr. Reddy's Laboratories Ltd. 12 May Q4FY26 weak neutral +2.6% +3.9% +1.6% — no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 sector peers reported the same week; the sector read may already have been set.
 ›
BIOCONBiocon Ltd. 7 May Q4FY26 weak wrong +2.1% +12.6% +15.1% +4% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 sector peers reported the same week; the sector read may already have been set.
 ›
LUPINLupin Ltd. 7 May Q4FY26 neutral neutral -8.3% -7.2% -4.8% +7% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 2 more
 ›
AJANTPHARMAjanta Pharmaceuticals Ltd. 5 May Q4FY26 unfavourable wrong +6.2% +10.0% +11.6% -2% no figures
  • Its sector moved +5.4% over the window.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 1 more
 ›
WOCKPHARMAWockhardt Ltd. 4 May Q4FY26 — unread +20.5% +13.7% +15.8% +17% no figures
  • Ran up 17% in the 30 sessions before the result — a good number had little left to reward.
  • Its sector moved +5.9% over the window.
  • 3 more
 ›
LAURUSLABSLaurus Labs Ltd. 30 Apr Q4FY26 strong right +5.7% +20.6% +22.0% +14% no figures
  • Its sector moved +6.4% over the window.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 1 more
 ›
PPLPHARMAPiramal Pharma Ltd. 28 Apr Q4FY26 neutral neutral -1.6% +6.1% +7.4% +18% no figures
  • Ran up 18% in the 30 sessions before the result — a good number had little left to reward.
  • Its sector moved +6.0% over the window.
  • 3 more
 ›
ALKEMAlkem Laboratories Ltd. 13 Feb Q3FY26 favourable right +1.0% +3.0% +5.4% -1% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Volume ran 1.7x its prior month in the fortnight before.
  • 1 more
 ›
IPCALABIpca Laboratories Ltd. 13 Feb Q3FY26 favourable right +0.4% +1.9% +4.2% +6% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 8 sector peers reported the same week; the sector read may already have been set.
 ›
TORNTPHARMTorrent Pharmaceuticals Ltd. 13 Feb Q3FY26 favourable right +4.4% +7.1% +9.5% +6% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 2 more
 ›
BIOCONBiocon Ltd. 12 Feb Q3FY26 unfavourable wrong +1.4% +3.9% +6.4% -5% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 8 sector peers reported the same week; the sector read may already have been set.
 ›
LUPINLupin Ltd. 12 Feb Q3FY26 strong right +0.5% +4.1% +6.5% +5% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 2 more
 ›
DIVISLABDivi's Laboratories Ltd. 11 Feb Q3FY26 neutral neutral -3.4% +1.4% +3.1% +0% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 8 sector peers reported the same week; the sector read may already have been set.
 ›
WOCKPHARMAWockhardt Ltd. 10 Feb Q3FY26 — unread -3.2% -3.6% -1.9% +0% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 8 sector peers reported the same week; the sector read may already have been set.
  • 1 more
 ›
AUROPHARMAAurobindo Pharma Ltd. 9 Feb Q3FY26 favourable neutral -4.7% -3.3% -1.6% -0% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Volume ran 2.3x its prior month in the fortnight before.
  • 1 more
 ›
ZYDUSLIFEZydus Lifesciences Ltd. 9 Feb Q3FY26 unfavourable neutral -2.7% -2.1% -0.4% +1% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 8 sector peers reported the same week; the sector read may already have been set.
 ›
SAILIFESai Life Sciences Ltd. 5 Feb Q3FY26 — unread +10.2% +16.1% +16.4% -10% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Delivery share rose 11 points in the fortnight before — someone was taking stock home.
  • 2 more
 ›
MANKINDMankind Pharma Ltd. 3 Feb Q3FY26 neutral neutral -3.8% -4.0% -4.4% -0% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 5% of its 52-week low.
 ›
SUNPHARMASun Pharmaceutical Industries Ltd. 31 Jan Q3FY26 unfavourable wrong +6.7% +6.6% +5.2% -11% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 5% of its 52-week low.
  • 2 more
 ›
AJANTPHARMAjanta Pharmaceuticals Ltd. 30 Jan Q3FY26 strong right +3.5% +5.7% +4.3% +7% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 sector peers reported the same week; the sector read may already have been set.
 ›
GLENMARKGlenmark Pharmaceuticals Ltd. 30 Jan Q3FY26 favourable neutral -3.1% +0.7% -0.7% +3% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Its reversal habit held this quarter.
  • 1 more
 ›
GLANDGland Pharma Ltd. 28 Jan Q3FY26 favourable right +9.3% +7.5% +5.6% +1% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 sector peers reported the same week; the sector read may already have been set.
 ›
PPLPHARMAPiramal Pharma Ltd. 28 Jan Q3FY26 unfavourable wrong +0.5% +6.1% +4.2% -10% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 5% of its 52-week low.
  • 2 more
 ›
CIPLACipla Ltd. 23 Jan Q3FY26 weak neutral +1.0% +2.1% -1.5% -13% no figures
  • The market itself moved +3.5% over the same ten sessions; the raw move is mostly tide.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 more
 ›
LAURUSLABSLaurus Labs Ltd. 23 Jan Q3FY26 strong wrong -1.7% -4.9% -8.5% -0% no figures
  • The market itself moved +3.5% over the same ten sessions; the raw move is mostly tide.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 1 more
 ›
DRREDDYDr. Reddy's Laboratories Ltd. 21 Jan Q3FY26 weak wrong +6.8% +7.3% +5.1% -7% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Its reversal habit held this quarter.
 ›
GLENMARKGlenmark Pharmaceuticals Ltd. 14 Nov Q2FY26 favourable neutral -2.8% +2.4% +1.4% -3% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 sector peers reported the same week; the sector read may already have been set.
 ›
ALKEMAlkem Laboratories Ltd. 13 Nov Q2FY26 strong neutral -0.0% -0.7% -2.0% +6% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 3% of its 52-week high.
  • 1 more
 ›
IPCALABIpca Laboratories Ltd. 13 Nov Q2FY26 weak wrong +12.5% +11.6% +10.4% -1% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 5% of its 52-week low.
  • 2 more
 ›
BIOCONBiocon Ltd. 11 Nov Q2FY26 favourable neutral +8.3% +3.5% +1.5% +8% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 sector peers reported the same week; the sector read may already have been set.
 ›
DIVISLABDivi's Laboratories Ltd. 7 Nov Q2FY26 favourable wrong -1.8% -4.5% -6.3% +10% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Its usual continuation pattern did not hold this quarter.
  • 1 more
 ›
Page 1 of 7 · 419 results Older →